Hookipa Pharma (HOOK) Short Interest Ratio & Short Volume → The CHIPS Act Motherlode (From True Market Insiders) (Ad) Free HOOK Stock Alerts $0.82 0.00 (0.00%) (As of 05/17/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Hookipa Pharma Short Interest DataCurrent Short Volume643,700 sharesPrevious Short Volume316,700 sharesChange Vs. Previous Month+103.25%Dollar Volume Sold Short$571,155.01Short Interest Ratio / Days to Cover0.8Last Record DateApril 30, 2024Outstanding Shares98,950,000 sharesFloat Size70,400,000 sharesShort Percent of Float0.91%Today's Trading Volume282,217 sharesAverage Trading Volume1,319,094 sharesToday's Volume Vs. Average21% Short Selling Hookipa Pharma ? Sign up to receive the latest short interest report for Hookipa Pharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatHOOK Short Interest Over TimeHOOK Days to Cover Over TimeHOOK Percentage of Float Shorted Over Time Ad True Market InsidersThe CHIPS Act MotherlodeIf you haven’t heard yet, the CHIPS Act is the US government pouring $280 BILLION into the manufacturing of US semiconductors. A lot of companies will make a fortune from this.Click here to see my #1 investment for 2024. Hookipa Pharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2024643,700 shares $571,155.01 +103.3%0.9%0.8 $0.89 4/15/2024316,700 shares $240,692.00 +0.3%0.5%0.5 $0.76 3/31/2024315,900 shares $224,920.80 -5.3%0.5%0.6 $0.71 3/15/2024333,400 shares $239,714.60 +11.3%0.6%0.1 $0.72 2/29/2024299,500 shares $230,016.00 -10.0%0.5%0.1 $0.77 2/15/2024332,600 shares $219,516.00 -25.4%0.6%0.1 $0.66 Get the Latest News and Ratings for HOOK and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Hookipa Pharma and its competitors with MarketBeat's FREE daily newsletter. 1/31/2024446,100 shares $277,072.71 -28.1%0.8%0.2 $0.62 1/15/2024620,200 shares $474,390.98 -21.0%1.0%0.3 $0.76 12/31/2023785,400 shares $636,174.00 +142.9%1.3%0.3 $0.81 12/15/2023323,300 shares $211,114.90 -29.6%0.4%0.1 $0.65 11/30/2023459,000 shares $261,171.00 +99.5%0.6%1 $0.57 11/15/2023230,100 shares $109,297.50 -26.7%0.3%0.5 $0.48 10/31/2023313,900 shares $135,604.80 -10.5%0.4%0.9 $0.43 10/15/2023350,800 shares $191,536.80 -12.1%0.5%0.9 $0.55 9/30/2023399,000 shares $245,784.00 +68.9%0.5%1 $0.62 9/15/2023236,200 shares $165,340.00 +5.2%0.3%0.5 $0.70 8/31/2023224,600 shares $147,113.00 -20.5%0.3%0.3 $0.66 8/15/2023282,400 shares $206,152.00 -2.0%0.4%0.3 $0.73 7/31/2023288,200 shares $227,678.00 -64.2%0.4%0.2 $0.79 7/15/2023805,900 shares $710,964.98 -11.5%1.2%0.5 $0.88 6/30/2023910,600 shares $801,328.00 +26.3%1.4%0.6 $0.88 6/15/2023721,000 shares $771,470.00 +951.0%1.1%0.5 $1.07 5/31/202368,600 shares $89,866.00 -78.2%0.1%0.1 $1.31 5/15/2023314,900 shares $585,714.00 No Change0.7%0.4 $1.86 10/31/2022879,900 shares $1.14 million -4.3%N/A0.9 $1.29 10/15/2022919,600 shares $1.09 million -9.8%N/A1 $1.19 9/30/20221,020,000 shares $1.37 million +2.0%N/A4.9 $1.34 9/15/20221,000,000 shares $1.41 million -3.9%N/A3.7 $1.41 8/31/20221,040,000 shares $1.55 million -17.5%N/A3.2 $1.49 8/15/20221,260,000 shares $2.17 million -46.2%N/A3.1 $1.73 7/31/20222,340,000 shares $3.21 million -2.5%N/A5.3 $1.37 7/15/20222,400,000 shares $3.96 million -29.6%N/A5.4 $1.65 6/30/20223,410,000 shares $5.56 million -14.1%N/A5.6 $1.63 6/15/20223,970,000 shares $6.67 million -3.6%N/A4.6 $1.68 5/31/20224,120,000 shares $7.09 million -0.7%N/A4.2 $1.72 5/15/20224,150,000 shares $5.69 million +2.7%N/A1.2 $1.37 4/30/20224,040,000 shares $6.06 million +5.2%N/A0.6 $1.50 4/15/20223,840,000 shares $6.87 million -2.5%N/A0.6 $1.79 3/31/20223,940,000 shares $8.98 million +1.8%N/A0.6 $2.28 3/15/20223,870,000 shares $5.84 million -16.8%N/A0.6 $1.51Bible Shocker: Have You Seen Elon Musk’s Miracle? (Ad)Breaking News: Elon Musk Invents New Type of A.I. (Shocking) Elon Musk is about to shock the world again with this new type of A.I.… Minting new millionaires in the process.Click here for the full story… HOOK Short Interest - Frequently Asked Questions What is Hookipa Pharma's current short interest? Short interest is the volume of Hookipa Pharma shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 643,700 shares of HOOK short. 0.91% of Hookipa Pharma's shares are currently sold short. Learn More on Hookipa Pharma's current short interest. What is a good short interest ratio for Hookipa Pharma? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. HOOK shares currently have a short interest ratio of 1.0. Learn More on Hookipa Pharma's short interest ratio. What is a good short interest percentage for Hookipa Pharma? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.91% of Hookipa Pharma's floating shares are currently sold short. Is Hookipa Pharma's short interest increasing or decreasing? Hookipa Pharma saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 643,700 shares, an increase of 103.3% from the previous total of 316,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Hookipa Pharma's float size? Hookipa Pharma currently has issued a total of 98,950,000 shares. Some of Hookipa Pharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Hookipa Pharma currently has a public float of 70,400,000 shares. How does Hookipa Pharma's short interest compare to its competitors? 0.91% of Hookipa Pharma's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Hookipa Pharma: Jaguar Health, Inc. (5.19%), Tempest Therapeutics, Inc. (9.42%), Rallybio Co. (9.67%), SCYNEXIS, Inc. (2.58%), Assembly Biosciences, Inc. (0.68%), Marinus Pharmaceuticals, Inc. (9.10%), InflaRx (0.22%), vTv Therapeutics Inc. (3.18%), MediciNova, Inc. (0.46%), SELLAS Life Sciences Group, Inc. (12.10%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Hookipa Pharma stock? Short selling HOOK is an investing strategy that aims to generate trading profit from Hookipa Pharma as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Hookipa Pharma? A short squeeze for Hookipa Pharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of HOOK, which in turn drives the price of the stock up even further. How often is Hookipa Pharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HOOK, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: JAGX Short Interest TPST Short Interest RLYB Short Interest SCYX Short Interest ASMB Short Interest MRNS Short Interest IFRX Short Interest VTVT Short Interest MNOV Short Interest SLS Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:HOOK) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingDems have chosen Biden replacement?Paradigm PressShocking $16T Elon Musk Crypto LeakCrypto 101 Media[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the MarketsBuy this small stock before coming AI Tidal WaveChaikin AnalyticsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders41 banks launch ‘crypto dollar’Stansberry Research